The list includes a number of common respiratory health conditions such as asthma, pneumonia, sleep apnoea and chronic ...

The holiday season is a time for joy, family and exciting celebrations. However, for those individuals living with chronic illnesses, managing their health during this time can be an added ...

The phase 1 clinical trial of APG333 is designed as a double-blind, placebo-controlled, first-in-human, single-ascending dose trial in healthy volunteers. It is expected to enroll approximately 32 ...

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulm ...

Apogee Therapeutics (APGE) announced that it has initiated dosing of healthy volunteers in its clinical trial of APG333, a novel, subcutaneous ...

By Dr Shivraj A.L. Chronic Obstructive Pulmonary Disease (COPD) is a lung condition that is progressive and debilitating in ...

Mepolizumab, a biologic approved for asthma, is not currently approved for COPD, but data from a 2017 study showed a trend ...

Massachusetts families are still struggling to find alternatives almost a year after GlaxoSmithKline canceled a widely ...

British drug maker GSK plc (GSK, GSK.L) announced Monday that the U.S. Food and Drug Administration has accepted for review, data ...

Upstream Bio's verekitug targets severe asthma, CRSwNP, and COPD, with promising early phase 2 data expected in 2025 and 2026 ...

This method even cuts the need for further treatment by 30 per cent. Doctors are hailing a new and "game changer" way to treat serious asthma and chronic obstructive pulmonary disease (COPD) attacks, ...